Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like Charles River Laboratories: Business Is Booming With 500 Positions Open May 4, 2017 Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018 5 Biotechs Quietly Hitting Unusual Volumes Right Now June 22, 2017
Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018